5 November 2020 - - US-based Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) has appointed Alexander Denner, Ph.D., to its board of directors, the company said.

Denner is the founding partner and chief investment officer of Sarissa Capital Management LP.

With the appointment of Dr. Denner, Ironwood's board of directors will now be comprised of 10 directors, eight of whom are independent.

Denner has been appointed to the governance and nominating committee of the board, effective as of November 9, 2020.

Denner is a founding partner and chief investment officer of Sarissa Capital Management LP, where he has been since 2011.

Sarissa Capital focuses on improving the strategies of companies to enhance shareholder value.

From 2006 to 2011, Dr. Denner served as a senior managing director at Icahn Capital L.P. Prior to that, he served as a portfolio manager at Viking Global Investors and Morgan Stanley Investment Management. Dr. Denner serves on the board of directors of Biogen Inc (NASDAQ: BIIB).

Ironwood Pharmaceuticals (NASDAQ: IRWD) is a GI-focused healthcare company dedicated to creating medicines that make a difference for patients living with GI diseases.

Ironwood was founded in 1998 and is headquartered in Boston, Mass.